Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Cell-based Assays Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Basic Research and Others), By End User, By Products & Services, By Regional Outlook and Forecast, 2022 - 2028

Published Date : 31-Oct-2022

Pages: 245

Formats: PDF

The Global Cell-based Assays Market size is expected to reach $24.9 billion by 2028, rising at a market growth of 8.2% CAGR during the forecast period.

Any type of experiment that is conducted inside a living cell is considered to be a cell-based assay. As a result of the breadth of this concept, there are a number of distinct cell-based tests. Assays that are performed on living cells can reveal information on a cell's viability, cytotoxicity, proliferation, senescence, as well as the death rate. These assays are based on reporter gene assays that have a high sensitivity due to the signal amplification that occurs during cell-signaling cascades.

Cell-based Assays Market - Global Opportunities and Trends Analysis Report 2018-2028

Because of this, these assays are suitable for conducting an investigation of cell-signaling cascades. High-throughput screening, or HTS, formats typically make use of cell-based assays. Research and development expenditures have been boosted by a number of governmental and private organizations in an effort to find safer and more effective drugs.

In addition, developments in the technology of cell-based assays have made it possible for researchers to apply this method for drug discovery as well as investigations of toxicology. Cell culture processes, in which living cells are generated in vitro and utilized as model systems for analyzing the physiology and biochemistry of both healthy and diseased cells, serve as the foundation for the cell-based assay methodology, which is based on the idea of the cell-based assay.

In a regulatory environment, cell-based assays are frequently used for cytotoxicity screening, to evaluate the biological activity (potency) of drug substance and drug product, to determine the method of action, early-stage proof of primary studies, and in immunogenicity experiments to determine if antibodies produced by the person are neutralizing the drug product.

COVID-19 Impact Analysis

The COVID-19 pandemic caused major clinical trials and the research processes involved in the creation of new drugs to be interrupted. Patients are now only treated symptomatically despite the fact that a number of vaccines or antiviral medications for COVID-19 have either been authorized or are currently in the development stage. When developing vaccines as well as treatments, it is necessary to evaluate the antibodies produced to determine the functional efficacy of the antibodies to inhibit the target virus. In order to decrease the amount of time required for these assays while also increasing their throughput, cell-based assays are used. Because of this, there has been a major rise in the demand for cell-based tests, which can give an early indication of the hazardous properties possessed by potential drug candidates.

Market Growth Factors

An increasing number of applications of cell-based assays within drug discovery applications

In the process of developing new drugs, cell-based assays are crucial components. In contrast to in vitro biochemical tests, cell-based assays offer a number of beneficial features. In contrast to biochemical assays, they provide responses that are tissue-specific and consistent while taking place in a microenvironment that is biologically relevant. A significant aspect that restricts the use of biochemical assays is the impossibility of preparing or purifying each and every target for biochemical measurement. This is one of the factors that contribute to the limitations of the applications of biochemical assays.

Rising adoption of novel and advanced approaches throughout developing economies

One of the major factors that are expediting the growth of the market is the significant number of developing countries all over the world. The low cost of labor and raw materials, the increased risk of infections, the growth in the number of research activities, and the technological advancements throughout the end-use sectors for cell-based assays in these emerging countries are anticipated to provide significant growth prospects for several major market players operating in the cell-based assays market.

Market Restraining Factors

High cost of maintenance and ownership of equipment

The incorporation of high-throughput screening (HTS) along with high-content screening (HCS) methods has expanded the reliability of cell-based assays. However, these innovations have significantly increased the price of instruments and devices that are required to conduct experiments. In addition, the time and expense associated with each HTS method are directly related to the complexity of the target molecule; hence, the greater the complexity, the larger the cost.

Application Outlook

By Application, the Cell-based Assays Market is segregated into Basic Research, Drug Discovery, and Other Applications. In 2021, the basic research segment acquired a significant revenue share of the cell-based assays market. The cell-based assays that make up the bulk of research in the life sciences are used with the goal of gaining a deeper comprehension of the myriad cellular processes that are involved in both health and illness. These assays are employed to identify an impact or event that occurred within a cell, examine the activities of genes, proteins, or the entire cell as well as the regulatory systems that control them, and screen for potential inducers or inhibitors for biological processes.

End-User Outlook

On the basis of End-user, the Cell-based Assays Market is categorized into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. In 2021, the pharmaceutical and biotechnology companies garnered a substantial revenue share of the cell-based assays market. In the pharmaceutical business, cell-based assays have shown to be an efficient method for determining the influence that external stimuli or pharmacological compounds have on the overall activity of cells. In addition, cell-based drug screening assays have become increasingly popular in the field of drug discovery research.

Cell-based Assays Market Share and Industry Analysis Report 2021

Products & Services Outlook

Based on Products and Services, the Cell-based Assays Market is segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Instruments & Software, and Cell Lines. In 2021, the assay kits segment acquired the largest revenue share of the cell-based assays market. The rapidly increasing growth of the segment is attributed to the fact that it is useful in a wide variety of applications within the biopharmaceutical industry. Additionally, analytical tests for the assessment of specific analytes are performed with the use of reagents that may be found in assay kits. These tests are utilized for a wide variety of applications in different industries. Because they provide diagnostics practitioners with results that can be relied upon, the particular assay kits in concern are in high demand because they significantly reduce ambiguity.

Cell-based Assays Market Report Coverage
Report Attribute Details
Market size value in 2021 USD 14.6 Billion
Market size forecast in 2028 USD 24.9 Billion
Base Year 2021
Historical Period 2018 to 2020
Forecast Period 2022 to 2028
Revenue Growth Rate CAGR of 8.2% from 2022 to 2028
Number of Pages 245
Number of Tables 385
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered Application, Products & Services, End-use, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • An increasing number of applications of cell-based assays within drug discovery applications
  • Rising adoption of novel and advanced approaches throughout developing economies
Restraints
  • High cost of maintenance and ownership of equipment

Regional Outlook

Region-Wise, the cell-based Assays Market is analyzed across north America, Europe, Asia-Pacific, and LAMEA. In 2021, North America accounted for the biggest revenue share of the cell-based assays market. The significant research that is carried out at a variety of research institutes all over the North American region and is jointly financed by university research institutes, as well as pharma giants across the region, is the primary factor that is bolstering the growth of the regional market. Furthermore, an increasing number of partnerships and collaborations within the region in order to boost the development of new and advanced approaches is fuelling the growth of the market in North America.

Free Valuable Insights: Global Cell-based Assays Market size to reach USD 24.9 Billion by 2028

KBV Cardinal Matrix - Cell-based Assays Market Competition Analysis

Cell-based Assays Market - Competitive Landscape and Trends by Forecast 2028

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. are the forerunners in the Cell-based Assays Market. Companies such as Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation are some of the key innovators in Cell-based Assays Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.

Strategies deployed in Cell-based Assays Market

» Partnerships, Collaborations and Agreements:

  • Aug-2022: BD came into an agreement with Labcorp, a leader in global life sciences. Under this partnership, the companies aimed to introduce a framework in order to innovate, develop, and market companion diagnostics based on flow cytometry with the aim to meet the requirements of patients for treatments for cancer as well as other diseases.
  • Mar-2022: Roche collaborated with Bristol Myers Squibb, an American multinational pharmaceutical company. With this collaboration, the companies aimed to further expedite two assays for clinical trial utilization through the introduction and deployment of two digital pathology algorithms.
  • Mar-2022: Promega came into an agreement with FUJIFILM Cellular Dynamics, a leader in providing human iPSC technologies. Under this agreement, the companies aimed to expedite the development of a new assay for drug discovery.
  • Feb-2022: Merck came into an agreement with Quris, an artificial intelligence company. Following this agreement, Merck aimed to evaluate the safety prediction platform of Quris in drug discovery projects.
  • Dec-2021: Lonza joined hands with Agilent, a leader in life sciences. This collaboration aimed to develop and deploy present as well as upcoming analytical technologies within patient-scale cell therapy production workflows through the Cocoon Platform.
  • Nov-2021: Thermo Fisher entered into an agreement with Cellenion, a BICO company. Through this agreement, the companies aimed to accelerate single-cell proteomics analyses with the integration of Cellenion’s proteoCHIPTM and cellenONE into TMT multiplexing technologies and Orbitrap Orbitrap mass spectrometers of Thermo Fisher. In addition, this integration would allow the companies to offer complete solutions ranging from automated sample preparation and single-cell isolation to mass spectrometry)-based proteomics analysis on single cells.
  • Oct-2021: Roche entered into a partnership with PathAI, an AI-powered technology leader in pathology. This acquisition aimed to develop and commercialize the AI-powered technology of PathAI via the uPath enterprise software of Roche. It would offer wide access to digital pathology diagnostics with the aim to support companion diagnostic programs and clinical research.
  • Jun-2021: Bio-Rad Laboratories entered into an agreement with Seegene, a leading biotechnology business. Following this agreement, Bio-Rad aimed to leverage the capabilities of Seegene in order to accelerate its penetration within the United States market by receiving FDA approvals for its clinical assays.
  • May-2021: Bio-Rad partnered with Roche, a Swiss multinational healthcare company. Under this partnership, the companies aimed to offer access to their customers to the complete range of Bio-Rad's InteliQ products as well as Unity QC data management solutions. Moreover, this partnership would also allow customers to leverage the support and training services of the companies.
  • Jan-2021: Charles River partnered with Cypre, a biotechnology company. Under this partnership, Cypre would offer access to its proprietary Falcon-X 3D tumor model platform to Charles River's customers. Moreover, it would also accelerate 3D in vitro testing services of Charles River to optimize immuno-oncological methods for its customers.

» Product Launches and Product Expansions:

  • May-2022: BD rolled out BD COR MX, an analytic instrument option. This solution aimed to fulfill the requirements of laboratories for high-throughput testing owing to advanced and innovative automation and lowering staff interaction through maximizing efficiencies across laboratory workflow.
  • Mar-2022: BD unveiled the BD Rhapsody TCR/BCR Multiomic Assay, a range of reagents. Through this launch, the company aimed to offer a solution to researchers to simply as well as comprehensively evaluate key cells within the immune system. Moreover, it would help in the advancement of immuno-oncology, autoimmune disorders, and infectious diseases.
  • Aug-2021: BD released BD COR PX/GX System, a fully automated high-throughput diagnostic system. Through this launch, the company aimed to redefine the concept of automation in molecular testing of infectious diseases throughout key laboratories as well as other centralized laboratories across the United States.
  • Mar-2022: Danaher launched the CellMek SPS, a fully automated sample preparation system. The manual solution is a robust data management and sample preparation to address clinical flow cytometry challenges through its ability to process multiple sample types on-demand with the aim to aid laboratories in expanding their capabilities.
  • Dec-2021: Roche introduced NAVIFY Oncology Hub, a digital solution. Through this launch, the company aimed to improve workflow optimization and clinical decision support for oncologists as well as oncology care teams. This solution would address Oncology challenges by aggregating and organizing diverse patient data securely throughout the IT systems of an institution.
  • Jun-2021: Corning rolled out HepGo, an Assay-ready 3D liver spheroid kit. This solution aimed to offer a simple way for customers to leverage 3D PHH liver spheroids for numerous applications, such as hepatotoxicity assays. In addition, the kit would also support biochemical or imaging-based assays with its pre-plated nature.
  • Aug-2020: Promega launched the Promega Lumit Dx SARS-CoV-2 Immunoassay, a serological antibody test for COVID-19. This in vitro diagnostic test aimed to offer a PPA sensitivity of 93.5% while being utilized and evaluated with samples from patients with diverse disease levels as well as 100% sensitivity within hospitalized patients.

» Acquisitions and Mergers:

  • Jun-2022: Charles River completed its acquisition of Explora BioLabs Holdings, a contract vivarium research services provider. This acquisition aimed to expand and support the operation of the company, which offers AAALAC-accredited.
  • Feb-2022: BD took over Cytognos, a Biotech company. Through this acquisition, the company aimed to expedite the strategy of BD to help in the management of chronic diseases by expanding its offerings, which include immune assessment tests, blood cancer diagnostics, and informatics with the aim to address the demands of clinicians, patients, and care providers.
  • May-2021: Roche took over GenMark Diagnostics, a leading vendor of multiplex molecular diagnostic solutions. This acquisition aimed to expand Roche's molecular diagnostics offerings to incorporate solutions with the capability to offer lifesaving information to patients, as well as their healthcare providers, rapidly.
  • Feb-2021: Charles River Laboratories acquired Cognate BioServices, a cell, and gene therapy CDMO. This acquisition aimed to incorporate a comprehensive range of research and manufacturing support solutions for early-stage diagnosis and treatment of diseases. In addition, it would allow the company to complement its strategy of establishing an individual scientific partner intending to offer an integrated solution to biopharmaceutical customers with the aim to aid in expediting their gene and cell therapy programs for non-clinical development and discovery.
  • Apr-2020: Bio-Rad Laboratories took over Celsee, an instruments and consumables provider. With this acquisition, the company aimed to expand its reach throughout the world in order to meet the rising demands of customers for single-cell analysis and precision medicine in order to offer improved insight into the disease along with its diagnosis as well as treatment.

» Approvals and Mergers:

  • Aug-2021: Roche received the US FDA approval for its VENTANA MMR, the first companion diagnostic test. With this approval, the company aimed to help patients in diagnosing deficient solid tumors in DNA MMR. Moreover, this approval would also complement the goal of the company to offer personalized healthcare via a test in order to identify which patients would be benefitted from targeted and specific therapies.

» Geographical Expansions:

  • Sep-2022: Thermo Fisher expanded its geographical footprint with the deployment of its dry-powder media production in Grand Island, New York. This geographical expansion aimed to aid the company in significantly reducing lead times for its customers to improve raw material supply assurance.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Drug Discovery
  • Basic Research
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Products & Services

  • Assay Kits
  • Reagents
  • Microplates
  • Probes & Labels
  • Instruments & Software
  • Cell Lines

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cell-based Assays Market, by Application
1.4.2 Global Cell-based Assays Market, by End User
1.4.3 Global Cell-based Assays Market, by Products & Services
1.4.4 Global Cell-based Assays Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2021, Jun) Leading Players

Chapter 4. Global Cell-based Assays Market by Application
4.1 Global Drug Discovery Market by Region
4.2 Global Basic Research Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Cell-based Assays Market by End-use
5.1 Global Pharmaceutical & Biotechnology Companies Market by Region
5.2 Global Academic & Research Institutes Market by Region
5.3 Global Contract Research Organizations (CROs) Market by Region

Chapter 6. Global Cell-based Assays Market by Products & Services
6.1 Global Assay Kits Market by Region
6.2 Global Reagents Market by Region
6.3 Global Microplates Market by Region
6.4 Global Probes & Labels Market by Region
6.5 Global Instruments & Software Market by Region
6.6 Global Cell Lines Market by Region

Chapter 7. Global Cell-based Assays Market by Region
7.1 North America Cell-based Assays Market
7.1.1 North America Cell-based Assays Market by Application
7.1.1.1 North America Drug Discovery Market by Country
7.1.1.2 North America Basic Research Market by Country
7.1.1.3 North America Others Market by Country
7.1.2 North America Cell-based Assays Market by End-use
7.1.2.1 North America Pharmaceutical & Biotechnology Companies Market by Country
7.1.2.2 North America Academic & Research Institutes Market by Country
7.1.2.3 North America Contract Research Organizations (CROs) Market by Country
7.1.3 North America Cell-based Assays Market by Products & Services
7.1.3.1 North America Assay Kits Market by Country
7.1.3.2 North America Reagents Market by Country
7.1.3.3 North America Microplates Market by Country
7.1.3.4 North America Probes & Labels Market by Country
7.1.3.5 North America Instruments & Software Market by Country
7.1.3.6 North America Cell Lines Market by Country
7.1.4 North America Cell-based Assays Market by Country
7.1.4.1 US Cell-based Assays Market
7.1.4.1.1 US Cell-based Assays Market by Application
7.1.4.1.2 US Cell-based Assays Market by End-use
7.1.4.1.3 US Cell-based Assays Market by Products & Services
7.1.4.2 Canada Cell-based Assays Market
7.1.4.2.1 Canada Cell-based Assays Market by Application
7.1.4.2.2 Canada Cell-based Assays Market by End-use
7.1.4.2.3 Canada Cell-based Assays Market by Products & Services
7.1.4.3 Mexico Cell-based Assays Market
7.1.4.3.1 Mexico Cell-based Assays Market by Application
7.1.4.3.2 Mexico Cell-based Assays Market by End-use
7.1.4.3.3 Mexico Cell-based Assays Market by Products & Services
7.1.4.4 Rest of North America Cell-based Assays Market
7.1.4.4.1 Rest of North America Cell-based Assays Market by Application
7.1.4.4.2 Rest of North America Cell-based Assays Market by End-use
7.1.4.4.3 Rest of North America Cell-based Assays Market by Products & Services
7.2 Europe Cell-based Assays Market
7.2.1 Europe Cell-based Assays Market by Application
7.2.1.1 Europe Drug Discovery Market by Country
7.2.1.2 Europe Basic Research Market by Country
7.2.1.3 Europe Others Market by Country
7.2.2 Europe Cell-based Assays Market by End-use
7.2.2.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.2.2.2 Europe Academic & Research Institutes Market by Country
7.2.2.3 Europe Contract Research Organizations (CROs) Market by Country
7.2.3 Europe Cell-based Assays Market by Products & Services
7.2.3.1 Europe Assay Kits Market by Country
7.2.3.2 Europe Reagents Market by Country
7.2.3.3 Europe Microplates Market by Country
7.2.3.4 Europe Probes & Labels Market by Country
7.2.3.5 Europe Instruments & Software Market by Country
7.2.3.6 Europe Cell Lines Market by Country
7.2.4 Europe Cell-based Assays Market by Country
7.2.4.1 Germany Cell-based Assays Market
7.2.4.1.1 Germany Cell-based Assays Market by Application
7.2.4.1.2 Germany Cell-based Assays Market by End-use
7.2.4.1.3 Germany Cell-based Assays Market by Products & Services
7.2.4.2 UK Cell-based Assays Market
7.2.4.2.1 UK Cell-based Assays Market by Application
7.2.4.2.2 UK Cell-based Assays Market by End-use
7.2.4.2.3 UK Cell-based Assays Market by Products & Services
7.2.4.3 France Cell-based Assays Market
7.2.4.3.1 France Cell-based Assays Market by Application
7.2.4.3.2 France Cell-based Assays Market by End-use
7.2.4.3.3 France Cell-based Assays Market by Products & Services
7.2.4.4 Russia Cell-based Assays Market
7.2.4.4.1 Russia Cell-based Assays Market by Application
7.2.4.4.2 Russia Cell-based Assays Market by End-use
7.2.4.4.3 Russia Cell-based Assays Market by Products & Services
7.2.4.5 Spain Cell-based Assays Market
7.2.4.5.1 Spain Cell-based Assays Market by Application
7.2.4.5.2 Spain Cell-based Assays Market by End-use
7.2.4.5.3 Spain Cell-based Assays Market by Products & Services
7.2.4.6 Italy Cell-based Assays Market
7.2.4.6.1 Italy Cell-based Assays Market by Application
7.2.4.6.2 Italy Cell-based Assays Market by End-use
7.2.4.6.3 Italy Cell-based Assays Market by Products & Services
7.2.4.7 Rest of Europe Cell-based Assays Market
7.2.4.7.1 Rest of Europe Cell-based Assays Market by Application
7.2.4.7.2 Rest of Europe Cell-based Assays Market by End-use
7.2.4.7.3 Rest of Europe Cell-based Assays Market by Products & Services
7.3 Asia Pacific Cell-based Assays Market
7.3.1 Asia Pacific Cell-based Assays Market by Application
7.3.1.1 Asia Pacific Drug Discovery Market by Country
7.3.1.2 Asia Pacific Basic Research Market by Country
7.3.1.3 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Cell-based Assays Market by End-use
7.3.2.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
7.3.2.2 Asia Pacific Academic & Research Institutes Market by Country
7.3.2.3 Asia Pacific Contract Research Organizations (CROs) Market by Country
7.3.3 Asia Pacific Cell-based Assays Market by Products & Services
7.3.3.1 Asia Pacific Assay Kits Market by Country
7.3.3.2 Asia Pacific Reagents Market by Country
7.3.3.3 Asia Pacific Microplates Market by Country
7.3.3.4 Asia Pacific Probes & Labels Market by Country
7.3.3.5 Asia Pacific Instruments & Software Market by Country
7.3.3.6 Asia Pacific Cell Lines Market by Country
7.3.4 Asia Pacific Cell-based Assays Market by Country
7.3.4.1 China Cell-based Assays Market
7.3.4.1.1 China Cell-based Assays Market by Application
7.3.4.1.2 China Cell-based Assays Market by End-use
7.3.4.1.3 China Cell-based Assays Market by Products & Services
7.3.4.2 Japan Cell-based Assays Market
7.3.4.2.1 Japan Cell-based Assays Market by Application
7.3.4.2.2 Japan Cell-based Assays Market by End-use
7.3.4.2.3 Japan Cell-based Assays Market by Products & Services
7.3.4.3 India Cell-based Assays Market
7.3.4.3.1 India Cell-based Assays Market by Application
7.3.4.3.2 India Cell-based Assays Market by End-use
7.3.4.3.3 India Cell-based Assays Market by Products & Services
7.3.4.4 South Korea Cell-based Assays Market
7.3.4.4.1 South Korea Cell-based Assays Market by Application
7.3.4.4.2 South Korea Cell-based Assays Market by End-use
7.3.4.4.3 South Korea Cell-based Assays Market by Products & Services
7.3.4.5 Singapore Cell-based Assays Market
7.3.4.5.1 Singapore Cell-based Assays Market by Application
7.3.4.5.2 Singapore Cell-based Assays Market by End-use
7.3.4.5.3 Singapore Cell-based Assays Market by Products & Services
7.3.4.6 Malaysia Cell-based Assays Market
7.3.4.6.1 Malaysia Cell-based Assays Market by Application
7.3.4.6.2 Malaysia Cell-based Assays Market by End-use
7.3.4.6.3 Malaysia Cell-based Assays Market by Products & Services
7.3.4.7 Rest of Asia Pacific Cell-based Assays Market
7.3.4.7.1 Rest of Asia Pacific Cell-based Assays Market by Application
7.3.4.7.2 Rest of Asia Pacific Cell-based Assays Market by End-use
7.3.4.7.3 Rest of Asia Pacific Cell-based Assays Market by Products & Services
7.4 LAMEA Cell-based Assays Market
7.4.1 LAMEA Cell-based Assays Market by Application
7.4.1.1 LAMEA Drug Discovery Market by Country
7.4.1.2 LAMEA Basic Research Market by Country
7.4.1.3 LAMEA Others Market by Country
7.4.2 LAMEA Cell-based Assays Market by End-use
7.4.2.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.4.2.2 LAMEA Academic & Research Institutes Market by Country
7.4.2.3 LAMEA Contract Research Organizations (CROs) Market by Country
7.4.3 LAMEA Cell-based Assays Market by Products & Services
7.4.3.1 LAMEA Assay Kits Market by Country
7.4.3.2 LAMEA Reagents Market by Country
7.4.3.3 LAMEA Microplates Market by Country
7.4.3.4 LAMEA Probes & Labels Market by Country
7.4.3.5 LAMEA Instruments & Software Market by Country
7.4.3.6 LAMEA Cell Lines Market by Country
7.4.4 LAMEA Cell-based Assays Market by Country
7.4.4.1 Brazil Cell-based Assays Market
7.4.4.1.1 Brazil Cell-based Assays Market by Application
7.4.4.1.2 Brazil Cell-based Assays Market by End-use
7.4.4.1.3 Brazil Cell-based Assays Market by Products & Services
7.4.4.2 Argentina Cell-based Assays Market
7.4.4.2.1 Argentina Cell-based Assays Market by Application
7.4.4.2.2 Argentina Cell-based Assays Market by End-use
7.4.4.2.3 Argentina Cell-based Assays Market by Products & Services
7.4.4.3 UAE Cell-based Assays Market
7.4.4.3.1 UAE Cell-based Assays Market by Application
7.4.4.3.2 UAE Cell-based Assays Market by End-use
7.4.4.3.3 UAE Cell-based Assays Market by Products & Services
7.4.4.4 Saudi Arabia Cell-based Assays Market
7.4.4.4.1 Saudi Arabia Cell-based Assays Market by Application
7.4.4.4.2 Saudi Arabia Cell-based Assays Market by End-use
7.4.4.4.3 Saudi Arabia Cell-based Assays Market by Products & Services
7.4.4.5 South Africa Cell-based Assays Market
7.4.4.5.1 South Africa Cell-based Assays Market by Application
7.4.4.5.2 South Africa Cell-based Assays Market by End-use
7.4.4.5.3 South Africa Cell-based Assays Market by Products & Services
7.4.4.6 Nigeria Cell-based Assays Market
7.4.4.6.1 Nigeria Cell-based Assays Market by Application
7.4.4.6.2 Nigeria Cell-based Assays Market by End-use
7.4.4.6.3 Nigeria Cell-based Assays Market by Products & Services
7.4.4.7 Rest of LAMEA Cell-based Assays Market
7.4.4.7.1 Rest of LAMEA Cell-based Assays Market by Application
7.4.4.7.2 Rest of LAMEA Cell-based Assays Market by End-use
7.4.4.7.3 Rest of LAMEA Cell-based Assays Market by Products & Services

Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Approvals and Trials:
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Geographical Expansions:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.5.4.2 Acquisition and Mergers:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
TABLE 1 Global Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 2 Global Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell-based Assays Market
TABLE 4 Product Launches And Product Expansions– Cell-based Assays Market
TABLE 5 Acquisition and Mergers– Cell-based Assays Market
TABLE 6 Geographical Expansions – Cell-based Assays Market
TABLE 7 Approvals and Trials – Cell-based Assays Market
TABLE 8 Global Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 9 Global Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 10 Global Drug Discovery Market by Region, 2018 - 2021, USD Million
TABLE 11 Global Drug Discovery Market by Region, 2022 - 2028, USD Million
TABLE 12 Global Basic Research Market by Region, 2018 - 2021, USD Million
TABLE 13 Global Basic Research Market by Region, 2022 - 2028, USD Million
TABLE 14 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 15 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 16 Global Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 17 Global Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 18 Global Pharmaceutical & Biotechnology Companies Market by Region, 2018 - 2021, USD Million
TABLE 19 Global Pharmaceutical & Biotechnology Companies Market by Region, 2022 - 2028, USD Million
TABLE 20 Global Academic & Research Institutes Market by Region, 2018 - 2021, USD Million
TABLE 21 Global Academic & Research Institutes Market by Region, 2022 - 2028, USD Million
TABLE 22 Global Contract Research Organizations (CROs) Market by Region, 2018 - 2021, USD Million
TABLE 23 Global Contract Research Organizations (CROs) Market by Region, 2022 - 2028, USD Million
TABLE 24 Global Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 25 Global Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 26 Global Assay Kits Market by Region, 2018 - 2021, USD Million
TABLE 27 Global Assay Kits Market by Region, 2022 - 2028, USD Million
TABLE 28 Global Reagents Market by Region, 2018 - 2021, USD Million
TABLE 29 Global Reagents Market by Region, 2022 - 2028, USD Million
TABLE 30 Global Microplates Market by Region, 2018 - 2021, USD Million
TABLE 31 Global Microplates Market by Region, 2022 - 2028, USD Million
TABLE 32 Global Probes & Labels Market by Region, 2018 - 2021, USD Million
TABLE 33 Global Probes & Labels Market by Region, 2022 - 2028, USD Million
TABLE 34 Global Instruments & Software Market by Region, 2018 - 2021, USD Million
TABLE 35 Global Instruments & Software Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Cell Lines Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Cell Lines Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Cell-based Assays Market by Region, 2018 - 2021, USD Million
TABLE 39 Global Cell-based Assays Market by Region, 2022 - 2028, USD Million
TABLE 40 North America Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 41 North America Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 42 North America Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 43 North America Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 44 North America Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 45 North America Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 46 North America Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 47 North America Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 48 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 49 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 50 North America Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 51 North America Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 52 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 53 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 54 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 56 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 59 North America Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 60 North America Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 61 North America Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 62 North America Reagents Market by Country, 2018 - 2021, USD Million
TABLE 63 North America Reagents Market by Country, 2022 - 2028, USD Million
TABLE 64 North America Microplates Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Microplates Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 70 North America Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 71 North America Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 72 North America Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 74 US Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 75 US Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 76 US Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 77 US Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 78 US Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 79 US Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 80 US Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 81 US Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 82 Canada Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 83 Canada Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 84 Canada Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 85 Canada Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 86 Canada Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 87 Canada Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 88 Canada Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 89 Canada Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 90 Mexico Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 91 Mexico Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 92 Mexico Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 93 Mexico Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 94 Mexico Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 95 Mexico Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 96 Mexico Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 97 Mexico Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 98 Rest of North America Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 99 Rest of North America Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 100 Rest of North America Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 101 Rest of North America Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 102 Rest of North America Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 103 Rest of North America Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 104 Rest of North America Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 105 Rest of North America Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 106 Europe Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 107 Europe Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 108 Europe Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 109 Europe Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 110 Europe Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 111 Europe Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 112 Europe Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 113 Europe Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 114 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 115 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 116 Europe Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 117 Europe Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 118 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 119 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 120 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 121 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 122 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 123 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 124 Europe Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 125 Europe Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 126 Europe Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 127 Europe Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 128 Europe Reagents Market by Country, 2018 - 2021, USD Million
TABLE 129 Europe Reagents Market by Country, 2022 - 2028, USD Million
TABLE 130 Europe Microplates Market by Country, 2018 - 2021, USD Million
TABLE 131 Europe Microplates Market by Country, 2022 - 2028, USD Million
TABLE 132 Europe Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 133 Europe Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 134 Europe Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 135 Europe Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 136 Europe Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 137 Europe Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 138 Europe Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 139 Europe Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 140 Germany Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 141 Germany Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 142 Germany Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 143 Germany Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 144 Germany Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 145 Germany Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 146 Germany Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 147 Germany Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 148 UK Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 149 UK Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 150 UK Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 151 UK Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 152 UK Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 153 UK Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 154 UK Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 155 UK Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 156 France Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 157 France Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 158 France Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 159 France Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 160 France Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 161 France Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 162 France Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 163 France Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 164 Russia Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 165 Russia Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 166 Russia Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 167 Russia Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 168 Russia Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 169 Russia Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 170 Russia Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 171 Russia Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 172 Spain Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 173 Spain Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 174 Spain Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 175 Spain Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 176 Spain Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 177 Spain Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 178 Spain Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 179 Spain Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 180 Italy Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 181 Italy Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 182 Italy Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 183 Italy Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 184 Italy Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 185 Italy Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 186 Italy Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 187 Italy Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 188 Rest of Europe Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 189 Rest of Europe Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 190 Rest of Europe Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 191 Rest of Europe Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 192 Rest of Europe Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 193 Rest of Europe Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 194 Rest of Europe Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 195 Rest of Europe Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 196 Asia Pacific Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 197 Asia Pacific Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 198 Asia Pacific Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 199 Asia Pacific Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 200 Asia Pacific Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 201 Asia Pacific Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 202 Asia Pacific Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 203 Asia Pacific Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 204 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 205 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 206 Asia Pacific Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 207 Asia Pacific Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 208 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 209 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 210 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 211 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 212 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 213 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 214 Asia Pacific Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 215 Asia Pacific Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 216 Asia Pacific Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 217 Asia Pacific Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 218 Asia Pacific Reagents Market by Country, 2018 - 2021, USD Million
TABLE 219 Asia Pacific Reagents Market by Country, 2022 - 2028, USD Million
TABLE 220 Asia Pacific Microplates Market by Country, 2018 - 2021, USD Million
TABLE 221 Asia Pacific Microplates Market by Country, 2022 - 2028, USD Million
TABLE 222 Asia Pacific Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 223 Asia Pacific Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 224 Asia Pacific Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 225 Asia Pacific Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 226 Asia Pacific Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 227 Asia Pacific Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 228 Asia Pacific Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 229 Asia Pacific Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 230 China Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 231 China Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 232 China Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 233 China Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 234 China Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 235 China Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 236 China Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 237 China Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 238 Japan Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 239 Japan Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 240 Japan Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 241 Japan Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 242 Japan Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 243 Japan Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 244 Japan Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 245 Japan Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 246 India Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 247 India Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 248 India Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 249 India Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 250 India Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 251 India Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 252 India Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 253 India Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 254 South Korea Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 255 South Korea Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 256 South Korea Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 257 South Korea Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 258 South Korea Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 259 South Korea Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 260 South Korea Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 261 South Korea Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 262 Singapore Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 263 Singapore Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 264 Singapore Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 265 Singapore Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 266 Singapore Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 267 Singapore Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 268 Singapore Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 269 Singapore Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 270 Malaysia Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 271 Malaysia Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 272 Malaysia Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 273 Malaysia Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 274 Malaysia Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 275 Malaysia Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 276 Malaysia Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 277 Malaysia Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 278 Rest of Asia Pacific Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 279 Rest of Asia Pacific Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 280 Rest of Asia Pacific Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 281 Rest of Asia Pacific Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 282 Rest of Asia Pacific Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 283 Rest of Asia Pacific Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 284 Rest of Asia Pacific Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 285 Rest of Asia Pacific Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 286 LAMEA Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 287 LAMEA Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 288 LAMEA Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 289 LAMEA Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 290 LAMEA Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 291 LAMEA Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 292 LAMEA Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 293 LAMEA Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 294 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 295 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 296 LAMEA Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 297 LAMEA Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 298 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 299 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 300 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 301 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 302 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 303 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 304 LAMEA Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 305 LAMEA Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 306 LAMEA Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 307 LAMEA Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 308 LAMEA Reagents Market by Country, 2018 - 2021, USD Million
TABLE 309 LAMEA Reagents Market by Country, 2022 - 2028, USD Million
TABLE 310 LAMEA Microplates Market by Country, 2018 - 2021, USD Million
TABLE 311 LAMEA Microplates Market by Country, 2022 - 2028, USD Million
TABLE 312 LAMEA Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 313 LAMEA Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 314 LAMEA Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 315 LAMEA Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 316 LAMEA Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 317 LAMEA Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 318 LAMEA Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 319 LAMEA Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 320 Brazil Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 321 Brazil Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 322 Brazil Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 323 Brazil Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 324 Brazil Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 325 Brazil Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 326 Brazil Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 327 Brazil Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 328 Argentina Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 329 Argentina Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 330 Argentina Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 331 Argentina Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 332 Argentina Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 333 Argentina Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 334 Argentina Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 335 Argentina Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 336 UAE Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 337 UAE Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 338 UAE Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 339 UAE Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 340 UAE Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 341 UAE Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 342 UAE Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 343 UAE Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 344 Saudi Arabia Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 345 Saudi Arabia Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 346 Saudi Arabia Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 347 Saudi Arabia Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 348 Saudi Arabia Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 349 Saudi Arabia Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 350 Saudi Arabia Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 351 Saudi Arabia Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 352 South Africa Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 353 South Africa Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 354 South Africa Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 355 South Africa Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 356 South Africa Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 357 South Africa Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 358 South Africa Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 359 South Africa Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 360 Nigeria Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 361 Nigeria Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 362 Nigeria Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 363 Nigeria Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 364 Nigeria Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 365 Nigeria Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 366 Nigeria Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 367 Nigeria Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 368 Rest of LAMEA Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 369 Rest of LAMEA Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 370 Rest of LAMEA Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 371 Rest of LAMEA Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 372 Rest of LAMEA Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 373 Rest of LAMEA Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 374 Rest of LAMEA Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 375 Rest of LAMEA Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 376 Key information – Becton, Dickinson and Company
TABLE 377 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 378 Key Information – Thermo Fisher Scientific, Inc.
TABLE 379 Key Information – Bio-Rad Laboratories, Inc.
TABLE 380 key information – Charles River Laboratories International, Inc.
TABLE 381 Key Information – Danaher Corporation
TABLE 382 key Information – Merck GrouP
TABLE 383 Key Information – Lonza Group AG
TABLE 384 Key Information – Corning Incorporated
TABLE 385 key Information – Promega Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Global Cell-based Assays Market Share by Application, 2021
FIG 6 Global Cell-based Assays Market Share by Application, 2028
FIG 7 Global Cell-based Assays Market by Application, 2018 - 2028, USD Million
FIG 8 Global Cell-based Assays Market Share by End-use, 2021
FIG 9 Global Cell-based Assays Market Share by End-use, 2028
FIG 10 Global Cell-based Assays Market by End-use, 2018 - 2028, USD Million
FIG 11 Global Cell-based Assays Market Share by Products & Services, 2021
FIG 12 Global Cell-based Assays Market Share by Products & Services, 2028
FIG 13 Global Cell-based Assays Market by Products & Services, 2018 - 2028, USD Million
FIG 14 Global Cell-based Assays Market Share by Region, 2021
FIG 15 Global Cell-based Assays Market Share by Region, 2028
FIG 16 Global Cell-based Assays Market by Region, 2018 - 2028, USD Million
FIG 17 Recent strategies and developments: Becton, Dickinson and Company
FIG 18 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 19 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 20 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 21 Recent strategies and developments: Charles River Laboratories
FIG 22 Recent strategies and developments: Promega Corp.

Purchase Full Report of
Cell-based Assays Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL